William Allan Corp boosted its position in shares of Chemed Co. (NYSE:CHE - Free Report) by 13.5% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 8,340 shares of the company's stock after buying an additional 989 shares during the quarter. Chemed makes up approximately 2.7% of William Allan Corp's holdings, making the stock its 15th largest holding. William Allan Corp owned about 0.06% of Chemed worth $4,418,000 as of its most recent filing with the SEC.
Several other large investors have also recently bought and sold shares of CHE. UMB Bank n.a. increased its position in shares of Chemed by 300.0% in the 4th quarter. UMB Bank n.a. now owns 52 shares of the company's stock valued at $28,000 after buying an additional 39 shares in the last quarter. Trust Co. of Vermont bought a new position in shares of Chemed in the 4th quarter valued at about $34,000. GAMMA Investing LLC grew its holdings in shares of Chemed by 60.5% in the 3rd quarter. GAMMA Investing LLC now owns 138 shares of the company's stock valued at $83,000 after acquiring an additional 52 shares in the last quarter. Sound Income Strategies LLC bought a new position in Chemed during the third quarter worth about $201,000. Finally, Farther Finance Advisors LLC grew its holdings in Chemed by 2,314.3% during the third quarter. Farther Finance Advisors LLC now owns 338 shares of the company's stock worth $203,000 after purchasing an additional 324 shares during the period. Institutional investors and hedge funds own 95.85% of the company's stock.
Insider Transactions at Chemed
In related news, VP Brian C. Judkins purchased 145 shares of the business's stock in a transaction that occurred on Monday, December 30th. The stock was acquired at an average cost of $519.50 per share, for a total transaction of $75,327.50. Following the completion of the purchase, the vice president now owns 1,678 shares in the company, valued at approximately $871,721. This represents a 9.46 % increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Spencer S. Lee sold 732 shares of the business's stock in a transaction that occurred on Wednesday, November 27th. The shares were sold at an average price of $575.62, for a total value of $421,353.84. Following the completion of the sale, the executive vice president now owns 18,287 shares of the company's stock, valued at approximately $10,526,362.94. This trade represents a 3.85 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 3.32% of the company's stock.
Wall Street Analysts Forecast Growth
A number of equities analysts recently commented on CHE shares. Royal Bank of Canada reduced their price target on Chemed from $697.00 to $633.00 and set an "outperform" rating for the company in a report on Tuesday, November 5th. StockNews.com upgraded Chemed from a "hold" rating to a "buy" rating in a report on Saturday, November 30th.
View Our Latest Stock Report on CHE
Chemed Trading Up 0.1 %
Shares of NYSE:CHE traded up $0.34 during trading on Tuesday, reaching $553.96. 24,952 shares of the stock were exchanged, compared to its average volume of 90,039. Chemed Co. has a 12 month low of $512.12 and a 12 month high of $654.62. The firm has a market cap of $8.34 billion, a PE ratio of 27.99, a PEG ratio of 2.16 and a beta of 0.48. The stock has a 50-day moving average price of $542.91 and a 200-day moving average price of $564.81.
About Chemed
(
Free Report)
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.
Further Reading
Before you consider Chemed, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Chemed wasn't on the list.
While Chemed currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
